Pills and Pens Bring Hope for Drug Companies in Diabetes Crunch

  • Companies develop oral treatments, work with Google parent
  • Diabetes market has unprecedented competition, Novo says

Drugmakers facing a price war in the diabetes market are betting on new technologies to withstand the competition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.